conbercept eye drop (KH906)
/ Chengdu Kanghong Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
January 02, 2020
An Exploratory Clinical Trial Evaluating the Tolerability and Efficacy of KH906 in Patients With Corneal Neovascularization
(clinicaltrials.gov)
- P1; N=39; Recruiting; Sponsor: Chengdu Kanghong Biotech Co., Ltd.
Clinical • New P1 trial
1 to 1
Of
1
Go to page
1